Literature DB >> 26780692

Staphylococcus aureus bacteremic pneumonia.

C De la Calle1, L Morata2, N Cobos-Trigueros2, J A Martinez2, C Cardozo2, J Mensa2, A Soriano2.   

Abstract

Staphylococcus aureus bacteremic pneumonia is an uncommon cause of hospitalization, with a high mortality rate. However, published reports are scarce and have included a small number of cases. All patients with S. aureus bacteremic pneumonia were prospectively collected in our institution from 2000 to 2014, and a retrospective revision was performed to identify risk factors associated with methicillin resistance and to update the mortality of this entity. A total of 98 patients were admitted: 57.1 % were due to methicillin-susceptible S. aureus (MSSA) and 42.8 % due to methicillin-resistant S. aureus (MRSA). In 40 patients (40.8 %), the infection was community acquired. Thirteen were ventilator-associated pneumonia episodes. The most frequent comorbidities were chronic lung disease (34.7 %), chronic renal failure (31.6 %), diabetes mellitus (29.6 %), and cardiovascular disease (31.6 %). Septic shock was present in 46 patients (46.9 %). The 30-day mortality was 46.9 %. MRSA infections occurred in older patients, more frequently with cardiovascular diseases, and they had received antibiotic treatment in the previous month more often than MSSA-infected patients. Patients with infection due to MSSA presented more frequently with septic shock, but they received more frequently appropriate empirical antibiotic therapy than patients with MRSA pneumonia (96 % vs. 38.1 %), and no differences in mortality were observed between both groups. In conclusion, S. aureus bacteremic pneumonia is a severe infection that, nowadays, affects people with comorbidities and the mortality is still high.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26780692     DOI: 10.1007/s10096-015-2566-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

2.  Epidemiological features, resistance genes, and clones among community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) isolates detected in northern Spain.

Authors:  María González-Domínguez; Cristina Seral; Yolanda Sáenz; Soledad Salvo; María José Gude; Nerea Porres-Osante; Carmen Torres; Francisco Javier Castillo
Journal:  Int J Med Microbiol       Date:  2012-11-21       Impact factor: 3.473

3.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

4.  Necrotizing pneumonia caused by Panton-Valentine leukocidin-producing methicillin-susceptible Staphylococcus aureus (MSSA).

Authors:  Vincenzo Catena; Marco Baiocchi; Paolo Lentini; Luigi Badolati; Monica Baccarin; Daniele D Del Monte; Alessandro Rubini
Journal:  Infez Med       Date:  2012-09

5.  Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus.

Authors:  Belen Tilahun; Andrew C Faust; Phyllis McCorstin; Anthony Ortegon
Journal:  Am J Crit Care       Date:  2015-01       Impact factor: 2.228

6.  Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia.

Authors:  C Andrew DeRyke; Thomas P Lodise; Michael J Rybak; Peggy S McKinnon
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  Bacteremic Staphylococcus aureus pneumonia.

Authors:  C Watanakunakorn
Journal:  Scand J Infect Dis       Date:  1987

8.  [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].

Authors:  M Ortega; F Marco; A Soriano; M Almela; J A Martínez; A Muñoz; J Mensa
Journal:  Rev Esp Quimioter       Date:  2008-06       Impact factor: 1.553

9.  Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections.

Authors:  Hang-Cheng Chen; Wen-Ling Lin; Chi-Chun Lin; Wen-Han Hsieh; Cheng-Hsien Hsieh; Meng-Huan Wu; Jiunn-Yih Wu; Chien-Chang Lee
Journal:  J Antimicrob Chemother       Date:  2012-12-21       Impact factor: 5.790

10.  Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Juliana Sartori; Elyara Fiorin Pacheco
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

View more
  20 in total

1.  Hospital-Wide Protocol Significantly Improved Appropriate Management of Patients with Staphylococcus aureus Bloodstream Infection.

Authors:  Kawisara Krasaewes; Saowaluck Yasri; Phadungkiat Khamnoi; Romanee Chaiwarith
Journal:  Antibiotics (Basel)       Date:  2022-06-20

2.  Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.

Authors:  Mariana Chumbita; Pedro Puerta-Alcalde; Carlota Gudiol; Nicole Garcia-Pouton; Júlia Laporte-Amargós; Andrea Ladino; Adaia Albasanz-Puig; Cristina Helguera; Alba Bergas; Ignacio Grafia; Enric Sastre; María Suárez-Lledó; Xavier Durà; Carlota Jordán; Francesc Marco; Maria Condom; Pedro Castro; Jose A Martínez; Josep Mensa; Alex Soriano; Jordi Carratalà; Carolina Garcia-Vidal
Journal:  Antimicrob Agents Chemother       Date:  2021-11-29       Impact factor: 5.938

3.  Itaconate ameliorates methicillin-resistant Staphylococcus aureus-induced acute lung injury through the Nrf2/ARE pathway.

Authors:  Gang Liu; Yaxian Wu; Sihao Jin; Jiaojiao Sun; Bin-Bin Wan; Jiru Zhang; Yingying Wang; Zhi-Qi Gao; Dan Chen; Shengpeng Li; Qingfeng Pang; Zhiqiang Wang
Journal:  Ann Transl Med       Date:  2021-04

4.  Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Authors:  Robert Strengen Bigseth; Håkon Sandholdt; Andreas Petersen; Christian Østergaard; Thomas Benfield; Louise Thorlacius-Ussing
Journal:  Microbiol Spectr       Date:  2022-04-19

5.  A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?

Authors:  Cristina Vazquez Guillamet; Rodrigo Vazquez; Jonas Noe; Scott T Micek; Marin H Kollef
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

6.  Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.

Authors:  Abiodun D Ogunniyi; Manouchehr Khazandi; Andrew J Stevens; Sarah K Sims; Stephen W Page; Sanjay Garg; Henrietta Venter; Andrew Powell; Karen White; Kiro R Petrovski; Geraldine Laven-Law; Eliane G Tótoli; Hérida R Salgado; Hongfei Pi; Geoffrey W Coombs; Dean L Shinabarger; John D Turnidge; James C Paton; Adam McCluskey; Darren J Trott
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

7.  Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with Staphylococcus aureus bacteremic pneumonia.

Authors:  Batu K Sharma-Kuinkel; Christine Tkaczyk; Jessica Bonnell; Li Yu; Andrey Tovchigrechko; David E Tabor; Lawrence P Park; Felicia Ruffin; Mark T Esser; Bret R Sellman; Vance G Fowler; Alexey Ruzin
Journal:  Clin Transl Immunology       Date:  2019-07-19

8.  [Antibiotic susceptibility of Staphylococcus aureus and Streptococcus pneumoniae in healthy carrier individuals in primary care in Barcelona area].

Authors:  Carles Llor; Albert Boada; Mariona Pons-Vigués; Elisabet Grenzner; Rosa Juvé; Jesús Almeda
Journal:  Aten Primaria       Date:  2017-04-14       Impact factor: 1.137

Review 9.  Intravenous Ceftriaxone Versus Multiple Dosing Regimes of Intravenous Anti-Staphylococcal Antibiotics for Methicillin-Susceptible Staphylococcus aureus (MSSA): A Systematic Review.

Authors:  Musaiwale M Kamfose; Francis G Muriithi; Thomas Knight; Daniel Lasserson; Gail Hayward
Journal:  Antibiotics (Basel)       Date:  2020-01-21

Review 10.  Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia.

Authors:  Jelle Vlaeminck; Dina Raafat; Kristin Surmann; Leen Timbermont; Nicole Normann; Bret Sellman; Willem J B van Wamel; Surbhi Malhotra-Kumar
Journal:  Toxins (Basel)       Date:  2020-11-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.